September 7th 2023
In a recent study, improvements in symptom severity and quality of life scores at years 1, 2, and 3 were seen in patients receiving hysterectomy, myomectomy, or uterine artery embolization.
23rd Annual International Congress on the Future of Breast Cancer® East
Register Now!
Patient, Provider, and Caregiver Connection™: Incorporating the Patient Journey into HS Diagnosis and Management Practices
View More
Patient, Provider, & Caregiver Connection: Individualizing Care in Multiple Sclerosis – Understanding Patient Challenges and the Role of Innovative Treatment
View More
Expert Illustrations & Commentaries™: Targeting Immune Cells to Treat Multiple Sclerosis
View More
15th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
View More
Community Practice Connections™: 14th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies
View More
4th Annual International Congress on the Future of Women’s Health™
View More
Uterine artery embolization versus myomectomy to treat uterine fibroids
June 13th 2022Women with symptomatic uterine fibroids achieved a greater improvement in quality of life with myomectomy than with uterine artery embolization (UAE), according to a randomized study published in the journal Health Technology Assessment.
Read More
FDA accepts Myfembree sNDA for bleeding associated with uterine fibroids
June 2nd 2022The US Food and Drug Administration has accepted to review the supplemental New Drug Application for Myfembree for the potential treatment of heavy menstrual bleeding associated with uterine fibroids for up to 2 years.
Read More
A call to action for treating uterine fibroids
May 17th 2022A call to action in the journal Reproductive Sciences hopes to empower health care providers to optimize their quality of care for women with uterine fibroids by relying on the best available evidence and best patient-centered practices.
Read More
Uterine fibroids and risk of depression, anxiety, and self-directed violence
March 29th 2022Women with uterine fibroids (UF) experience higher rates of depression, anxiety, and self-directed violence, especially those with pain or who have had a hysterectomy, according to a study published in the Journal of Epidemiology and Community Health.
Read More
Ultrasound for uterine fibroids
March 17th 2022“Although traditional surgical treatments can resolve the clinical symptoms, they have many disadvantages, such as relatively large trauma, high chances of postoperative complications and long operation time,” wrote the authors of the review in the International Journal of Hyperthermia.
Read More
Myomectomy surgical choice considerations
March 17th 2022A recent study compared the effectiveness of open, laparoscopic, and robotic surgery in terms of outcomes and post-operative pregnancy success, and found that minimally invasive methods were best, according to a study published in JBRA Assisted Reproduction.
Read More
Uterine artery embolization or myomectomy for uterine fibroids
February 11th 2022A 4-year follow-up of a randomized control study comparing uterine artery embolization (UAE) to myomectomy for treating women with uterine fibroids has concluded that myomectomy achieves greater improvement in quality of life.
Read More
Analysis shows steep costs for uterine fibroid and heavy menstrual bleeding treatment
February 11th 2022Uterine fibroids (UF) with heavy menstrual bleeding (HMB) pose a significant economic burden—mostly due to surgical and procedural costs and treatment, according to a claims analysis in the Journal of Women’s Health.
Read More
A look at the current state of uterine fibroid care
February 10th 2022“Over 70% of women are estimated to develop uterine fibroids by age 50,” said senior author Irene Aninye, PhD, chief science officer for the Society for Women’s Health Research (SWHR) in Washington, D.C. “Fibroids are a complex condition that can range from being asymptomatic to having deleterious effects on a woman’s health and quality of life.”
Read More
Relugolix for treating uterine fibroids
January 19th 2022A phase 2, multicenter study has found relugolix (Myfembree; Myovant Sciences) significantly decreases menstrual blood loss in women with uterine leiomyomas and is mostly well tolerated. Relugolix is a small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.
Read More
Disparities for Black women with uterine fibroids
December 17th 2021Many of the glaring disparities that exist in care for the 26 million women in the United States who suffer from uterine fibroids, which disproportionately affects up to 80% of Black women, are being aggressively addressed though a new multifaceted campaign called UNmuting Fibroids.
Read More
The relationship between uterine fibroids and infertility
November 12th 2021Due to uterine fibroids being a potential cause of infertility, treatment options like myomectomy should be discussed individually with the patient, according to an article published in Diagnostics that evaluated the relationship.
Read More
PFAS in drinking water and its impact on the female reproductive system
September 7th 2021A Swedish cohort study in the journal Environment International has found that women of fertile age who were exposed to high levels of perfluorinated substances (PFAS) in drinking water were significantly more likely to subsequently have a diagnosis of polycystic ovarian syndrome (PCOS) and possibly uterine leiomyoma (or uterine fibroids [UFs]), but not endometriosis.
Read More
The impact of nutrition on gynecological diseases
August 20th 2021Several dietary supplements and nutrients potentially provide benefits in preventing and treating common gynecological diseases like uterine fibroids (UFs), endometriosis, polycystic ovarian syndrome (PCOS), infertility, menstrual disorders and vaginal infections, according to an article in the journal Nutrients.
Read More
Emergency department visits increase for fibroids, while hospital admissions decrease
August 12th 2021Emergency department (ED) visits in women affected by leiomyomas, or uterine fibroids (UFs), are increasing, but hospital admissions for this patient population are decreasing, according to a study published in the journal Obstetrics & Gynecology.
Read More